Kiniksa Pharmaceuticals L... (KNSA)
NASDAQ: KNSA
· Real-Time Price · USD
33.36
0.08 (0.24%)
At close: Aug 15, 2025, 3:59 PM
33.38
0.06%
After-hours: Aug 15, 2025, 04:54 PM EDT
Kiniksa Pharmaceuticals Balance Sheet Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Cash & Equivalents | 192.04M | 157.13M | 183.58M | 97.38M | 99.27M | 141.08M | 107.95M | 117.83M | 112.57M | 80.62M | 122.72M | 175.76M | 94.31M | 63.32M | 122.47M | 190.18M | 167.95M | 119.86M |
Short-Term Investments | 115.75M | 111.21M | 60.05M | 126.4M | 119.49M | 72.47M | 98.42M | 83.26M | 72.42M | 106.88M | 67.89M | 24.96M | 43.9M | 82.25M | 59.73M | 10M | 57.91M | 144.17M |
Long-Term Investments | n/a | n/a | n/a | n/a | n/a | -244.95M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Long-Term Assets | 8.2M | 8.2M | 10.31M | 7.85M | 7.9M | 249.08M | 827K | 2.29M | 2.35M | 7.55M | 5.82M | 5.63M | 5.67M | 5.92M | 8.72M | 6.55M | 5.81M | 5.8M |
Receivables | 31.91M | 40.06M | 41.72M | 24.89M | 20.45M | 15.99M | 21.27M | 3.04M | 24.65M | 7.42M | 20.32M | 11.16M | 7.81M | 29.44M | 3.98M | 3.22M | 2.55M | n/a |
Inventory | 48.18M | 22.07M | 26.36M | 28.68M | 34.86M | 27.28M | 31.12M | 25.58M | 23.96M | 23.43M | 21.6M | 14.62M | 19.92M | 13.22M | 3.67M | 5.61M | 6.38M | 2.19M |
Other Current Assets | 32.44M | 25.43M | 20.08M | 33.95M | 26.95M | 13.77M | 17.54M | 26.4M | 12.44M | 13.16M | 10.54M | 15.31M | 14.01M | 10.52M | 6.58M | 8.5M | 210K | 210K |
Total Current Assets | 420.31M | 355.91M | 331.8M | 311.3M | 301.02M | 270.59M | 276.3M | 256.11M | 184.99M | 231.5M | 243.06M | 241.81M | 179.94M | 198.76M | 196.45M | 217.51M | 244.81M | 275.56M |
Property-Plant & Equipment | 11.38M | 11.06M | 11.04M | 11.66M | 12.4M | 13.04M | 12.66M | 13.59M | 14.33M | 1.39M | 7.04M | 8.17M | 6.22M | 7.29M | 8.38M | 9.3M | 8.84M | 9.8M |
Goodwill & Intangibles | 15.75M | 16M | 16.25M | 16.5M | 16.75M | 17M | 17.25M | 17.5M | 17.75M | 18M | 18.25M | 18.5M | 18.75M | 19M | 19.25M | 19.5M | 19.75M | 20M |
Total Long-Term Assets | 240.84M | 243.42M | 248.75M | 244M | 241.41M | 249.08M | 250.03M | 226.95M | 238.29M | 211.36M | 216.61M | 218.14M | 30.64M | 32.21M | 36.35M | 35.35M | 34.4M | 35.59M |
Total Assets | 661.15M | 599.33M | 580.55M | 555.3M | 542.43M | 519.67M | 526.32M | 483.06M | 484.33M | 442.86M | 459.67M | 459.95M | 210.58M | 230.97M | 232.8M | 252.86M | 279.21M | 311.16M |
Account Payables | 8.96M | 1.98M | 2.04M | 8.33M | 7.39M | 5.63M | 8.25M | 1.01M | 648K | 1.39M | 7.9M | 1.47M | 2.52M | 3.38M | 1.87M | 1.65M | 4.16M | 2.76M |
Deferred Revenue | 31.81M | n/a | n/a | n/a | 12K | 156K | 307K | 2.56M | 4.67M | 6.5M | 12M | 12.09M | 12M | 12M | 38.03M | 28.53M | 31.06M | n/a |
Short-Term Debt | 2.52M | n/a | n/a | n/a | 2.08M | 2.28M | 2.25M | 2.31M | 2.24M | 3.48M | n/a | 3.27M | 3.34M | 3.31M | n/a | 3.25M | 2.64M | 2.37M |
Other Current Liabilities | 74.54M | 95.28M | 33.12M | 70.48M | 61.23M | 46.55M | 34.65M | 33M | 28.43M | 16.09M | 24.65M | 28.07M | 26.94M | 35.41M | 1.54M | 6.11M | 6.18M | 20.81M |
Total Current Liabilities | 117.83M | 97.27M | 100.62M | 95.95M | 84.29M | 64.21M | 63.67M | 53.47M | 47.47M | 36.59M | 47.07M | 56.49M | 43.54M | 50.35M | 44.82M | 34.43M | 38.78M | 35.45M |
Long-Term Debt | 7.24M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Long-Term Liabilities | 41.07M | 44.57M | 1.82M | 1.96M | 1.93M | 1.89M | 1.86M | 1.95M | 1.92M | 1.88M | 1.84M | 1.82M | 260K | 271K | 270K | 885K | 1.14M | 809K |
Total Long-Term Liabilities | 48.32M | 44.57M | 41.5M | 22.34M | 23.04M | 23.57M | 23.82M | 24.47M | 25.2M | 16.18M | 16.46M | 19.45M | 13.54M | 14.37M | 2.94M | 4.38M | 4.64M | 5.01M |
Total Liabilities | 166.14M | 141.84M | 142.12M | 118.29M | 107.33M | 87.78M | 87.48M | 77.94M | 72.68M | 52.77M | 63.52M | 75.94M | 57.08M | 64.72M | 47.76M | 38.81M | 43.42M | 40.46M |
Total Debt | 9.77M | 9.91M | 9.86M | 10.6M | 11.4M | 12.14M | 12.26M | 12.96M | 13.52M | 5.62M | 5.92M | 6.71M | 4.61M | 5.41M | 6.05M | 6.75M | 6.14M | 6.57M |
Common Stock | 21K | 20K | 20K | 20K | 20K | 20K | 20K | 15K | 14K | 14K | 19K | 19K | 19K | 19K | 18K | 18K | 18K | 18K |
Retained Earnings | -494.77M | -512.6M | -521.14M | -512.25M | -499.56M | -495.65M | -477.95M | -503.19M | -489.33M | -504.3M | -492.03M | -496.5M | -720.59M | -700.61M | -675.4M | -639.06M | -608.52M | -566.96M |
Comprehensive Income | -53K | -165K | -163K | -41K | -130K | -53K | 6K | -1K | 13K | 55K | 44K | -70K | -90K | -103K | -66K | -45K | 27K | -21K |
Shareholders Equity | 495.01M | 457.49M | 438.44M | 437.01M | 435.1M | 431.89M | 438.84M | -503.19M | -489.33M | -504.3M | -492.03M | -496.5M | -720.59M | -700.61M | 185.04M | 214.05M | 235.78M | 270.7M |
Total Investments | n/a | 111.21M | 60.05M | 126.4M | 119.49M | 72.47M | 98.42M | 83.26M | 72.42M | 106.88M | 67.89M | 24.96M | 43.9M | 82.25M | 59.73M | 10M | 57.91M | 144.17M |